Location History:
- Zoersel, BE (2008 - 2014)
- Beerse, BE (2020)
Company Filing History:
Years Active: 2008-2020
Title: Innovations by Greta Constantia Peter Vanhoof
Introduction
Greta Constantia Peter Vanhoof is a notable inventor based in Zoersel, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes related to various disorders. With a total of five patents to her name, her work has the potential to impact the treatment of neurological, psychiatric, and metabolic diseases.
Latest Patents
One of her latest patents involves novel 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives. This invention focuses on inhibitors of phosphodiesterase 2 (PDE2) and phosphodiesterase 10 (PDE10). The patent outlines pharmaceutical compositions that include these compounds, processes for their preparation, and their use in treating disorders associated with PDE2 and PDE10. Additionally, the invention includes radiolabelled compounds useful for imaging and quantifying the PDE2 enzyme in tissues using positron-emission tomography (PET). Another significant patent pertains to imidazo[1,2-a]pyrazine derivatives, which serve as inhibitors of the PDE10 enzyme. These compounds are aimed at preventing or treating neurological, psychiatric, and metabolic disorders.
Career Highlights
Greta is currently employed at Janssen Pharmaceutica NV, a leading pharmaceutical company known for its innovative research and development. Her work at Janssen has allowed her to focus on creating effective treatments for complex health issues, contributing to the advancement of medical science.
Collaborations
Throughout her career, Greta has collaborated with esteemed colleagues, including Joannes Theodorus Maria Linders and Gustaaf Henri Maria Willemsens. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Greta Constantia Peter Vanhoof is a pioneering inventor whose work in pharmaceutical innovations holds promise for the treatment of various disorders. Her contributions through her patents reflect her commitment to advancing medical science and improving patient outcomes.